Revvity, Inc. (RVTY), a health science solutions company, on Tuesday reported higher net income in the first quarter compared with the previous year.
For the first quarter, income from operations increased to $40.89 million from $41.67 million in the previous year.
Earnings per share were $0.37 versus 0.35 last year.
On a pro forma basis, earnings per share were 0.40 versus loss per share of $0.13 last year.
Adjusted earnings per share were $1.06 versus 1.01 last year.
On a pro forma basis, adjusted earnings per share were $1.04 versus $0.95 last year.
Operating income rose to $75.89 million from $72.23 million in the same period a year ago.
On a pro forma basis, operating income surged to $80.08 million from $20 million in the prior year.
Revenue increased to $711.12 million from $664.76 million in the previous year.
On a pro forma basis, revenue also jumped to $686.91 million from $628.70 million in the prior year.
Looking ahead, the company forecasts pro forma revenue of $2.81to $2.84 billion and pro forma adjusted earnings per share of $5.20 to $5.30.
Further, the company plans to divest its China Immunodiagnostics business, which accounted for about 6% of fiscal 2025 revenue, with a deal expected to be signed in the second quarter of 2026 and completed in 2027.
In the pre-market, Revvity is 3.01% higher at $89.11 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.